[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:appendix-carcinoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":109,"states":110},"Appendix Carcinoma",16,12,[8,15,21,27,34,41,48,54,60,66,72,78,84,91,97,103],{"nct_id":9,"title":10,"phases":11,"status":12,"updated_at":13,"content_modified":14},"NCT07291180","A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for High-Grade Appendiceal and Colorectal Adenocarcinoma With Peritoneal Metastasis",[],"RECRUITING","2026-08-26T02:17:11.311767Z","2026-05-05T02:43:29.677108Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT06101277","Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)",[],"2026-08-26T02:16:24.970704Z","2026-07-05T05:32:16.744017Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":25,"content_modified":26},"NCT05780684","Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer",[],"2026-08-26T02:15:26.669629Z","2026-05-05T02:43:29.333324Z",{"nct_id":28,"title":29,"phases":30,"status":12,"updated_at":32,"content_modified":33},"NCT04779554","Flat Dose vs. Weight-based IP Chemotherapy for CRS\u002FHIPEC",[31],"Phase 2","2026-08-26T02:17:49.709549Z","2026-05-05T02:43:29.211813Z",{"nct_id":35,"title":36,"phases":37,"status":12,"updated_at":39,"content_modified":40},"NCT04329494","PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer",[38],"Phase 1","2026-08-26T02:16:55.892527Z","2026-05-05T02:43:29.071231Z",{"nct_id":42,"title":43,"phases":44,"status":12,"updated_at":46,"content_modified":47},"NCT05674825","Investigation of Profile-related Evidence Determining Individualized Cancer Therapy for Patients With Aggressive Malignancies and Poor Prognoses",[45],"Phase 1\u002FPhase 2","2026-08-26T02:15:20.225313Z","2026-05-05T02:43:27.840688Z",{"nct_id":49,"title":50,"phases":51,"status":12,"updated_at":52,"content_modified":53},"NCT05969860","At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer",[31],"2026-08-26T02:17:20.511551Z","2026-05-05T02:43:26.978986Z",{"nct_id":55,"title":56,"phases":57,"status":12,"updated_at":25,"content_modified":59},"NCT07124351","Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)",[58],"Phase 4","2026-05-05T02:35:31.762467Z",{"nct_id":61,"title":62,"phases":63,"status":12,"updated_at":64,"content_modified":65},"NCT04847063","Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies",[38],"2026-08-26T02:16:45.157238Z","2026-05-05T02:43:28.478718Z",{"nct_id":67,"title":68,"phases":69,"status":12,"updated_at":70,"content_modified":71},"NCT05734430","Genetics of Appendix Cancer Study",[],"2026-08-26T02:19:22.562392Z","2026-05-13T02:55:06.373702Z",{"nct_id":73,"title":74,"phases":75,"status":12,"updated_at":76,"content_modified":77},"NCT06263088","EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.",[],"2026-08-26T02:19:04.543908Z","2026-05-05T02:43:27.634026Z",{"nct_id":79,"title":80,"phases":81,"status":12,"updated_at":82,"content_modified":83},"NCT07283939","Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays",[],"2026-08-26T02:17:53.433613Z","2026-05-05T02:35:31.698471Z",{"nct_id":85,"title":86,"phases":87,"status":88,"updated_at":89,"content_modified":90},"NCT07060014","NALIRIFOX (Nal-IRI Plus 5-FU\u002FLV Plus Oxaliplatin) as First-Line Treatment for Patients With Advanced Small Intestine and Appendiceal Cancers",[38],"NOT_YET_RECRUITING","2026-08-26T02:18:53.782384Z","2026-05-05T02:43:26.935975Z",{"nct_id":92,"title":93,"phases":94,"status":88,"updated_at":19,"content_modified":96},"NCT07271355","Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial",[95],"Phase 3","2026-04-29T02:57:57.074805Z",{"nct_id":98,"title":99,"phases":100,"status":88,"updated_at":101,"content_modified":102},"NCT07658196","TLR9 Immunotherapy for Peritoneal Carcinomatosis",[38],"2026-08-26T02:18:32.765187Z","2026-06-18T12:24:03.102969Z",{"nct_id":104,"title":105,"phases":106,"status":88,"updated_at":107,"content_modified":108},"NCT07487168","Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors",[38],"2026-08-26T02:16:33.772093Z","2026-05-05T02:43:27.075559Z",[],[111,115],{"state":112,"count":113,"slug":114},"California",5,"california",{"state":116,"count":117,"slug":118},"Florida",4,"florida"]